ORDER
REPRINTS
148
DONATE ET AL.
maintained at 0◦C under nitrogen atmosphere. After stirring for 10 min at 0◦C,
the solution was cooled to −78◦C and, after 15 min, a solution of compound
11 (R = CH3) (200.7 mg, 1.05 mmol) in anhydrous THF (2 mL) was added.
Stirring was continued for 30 min, and then a solution of phenylselenenyl chlo-
ride (201 mg, 1.05 mmol) in THF (1 mL) was added. After stirring for 2 h at
−20◦C, the reaction mixture was quenched by addition of a saturated aqueous
solution of NH4Cl, diluted with water, and extracted with ether. The ethereal
solution was washed with water, dried over anhydrous magnesium sulfate, and
evaporated. The residue was purified by column chromatography through silica
gel, eluting with hexane:ethyl acetate (9:1), to give 231.8 mg (64%) compound
1
13 as yellow solid mp 122◦–124◦C; H NMR (CDCl3) δ 7.82–6.90 (m, 9H),
5.91 (d, 1H, J = 5.7 Hz), 4.25 (d, 1H, J = 5.7 Hz), 1.41 (s, 3H); 13C NMR
(CDCl3) δ 175.1 (C), 157.2 (C), 138.1 (CH), 130.5 (CH), 130.2 (CH), 129.5
(CH), 126.8 (C), 122.3 (CH), 111.3 (CH), 104.7 (CH), 54.7 (CH), 47 (C), 20.5
(CH3); MS m/z (rel. intensity) 346 (M+, 17), 161 (100), 158 (28), 145 (13),
77 (29); Anal. calcd for C17H14O3Se: C, 59.3; H, 4.07. Found: C, 59.54; H,
4.21.
3-Methylene-3a,8a-dihydrobenzo[b]furano[3,2-d]furan-2-one (14)
and 3-methyl-8a-hydrobenzo[b]furano[3,2-d]furan-2-one (14a) (13,14)
Aqueous H2O2 (30%, 0.5 mL) was added to a solution of compound 13
(226.1 mg, 0.65 mmol) in dichlorometane (2 mL), and cooled at 0◦C. The reaction
mixture was stirred at room temperature for 40 min and then diluted with water. The
organic layer was washed with water, dried over anhydrous magnesium sulfate, and
evaporated. The residue was purified by column chromatography through silica
gel, eluting with hexane:ethyl acetate (9:1), to give the compounds 14 (48.4 mg,
39%) and 14a (62.4 mg, 51%).
Compound 14: mp 120◦–122◦C; 1H NMR (CDCl3) δ 7.32–6.81 (m, 4H),
6.55 (d, 1H, J = 6.2 Hz), 6.35 (d, 1H, J = 1.8 Hz), 6.01 (d, 1H, J = 1.8 Hz), 4.70
(d, 1H, J = 6.2 Hz); 13C NMR (CDCl3) δ 167.4 (C), 157.3 (C), 135.4 (C), 130.1
(CH), 125.0 (C), 124.2 (CH), 123.7 (CH2), 122.9 (CH), 111.0 (CH), 105.0 (CH),
47.1 (CH); MS m/z (rel. intensity) 188 (M+, 23), 159 (100), 131 (40), 115 (57),
105 (13), 77 (29), 63 (12); Anal. calcd for C11H8O3: C, 70.21; H, 4.26. Found: C,
70.35; H, 4.16.
1
Compound 14a: mp 92◦–94◦C; H NMR (CDCl3) δ 7.32–7.01 (m, 4H),
6.57 (q, 1H, J = 1.9 Hz), 2.07 (d, 3H, J = 1.9 Hz); 13C NMR (CDCl3) δ 172.7
(C), 163.6 (C), 160.6 (C), 133.3 (CH), 124.2 (CH), 123.1 (CH), 122.5 (C), 120.6
(C), 112.5 (CH), 106.9 (CH), 9.86 (CH3); MS m/z (rel. intensity) 188 (M+, 54),
160 (19), 131 (100), 115 (27), 103 (23), 77 (30), 63 (20), 51 (26); Anal. calcd for
C11H8O3: C, 70.21; H, 4.26. Found: C, 70.32; H, 4.31.